British pharmaceutical company GSK has agreed to pay $2.3 billion to settle lawsuits alleging that its heart burn medication Zantac caused cancer. GSK has settled 80,000 Zantac lawsuit. Watch to know more.

Pharmaceutical Giant GSK Reaches Major Settlement

British pharmaceutical company GSK said on Wednesday that it has agreed to pay $2.3 billion to put an end to lawsuits in the United States alleging that its heartburn drug Zantac caused cancer.

Pharma company GSK agrees to pay $2.3bn in US settlements on lawsuits over Zantac cancer claims

British pharmaceutical company GlaxoSmithKline (GSK) has opened up a front against American pharma giant Pfizer by filing a lawsuit in a Delaware court on Wednesday (August 2).

Battle of pharma giants: GSK sues Pfizer for patent infringement over RSV vaccine

A US Food and Drug Administration panel on Wednesday recommended two vaccines one each by Pfizer and GSK (GlaxoSmithKline) for their use in the United States against preventing Respiratory Syncytial Virus Infection (RSV) illness.

FDA panel recommends Pfizer, GSK vaccines against RSV for older adults, what is RSV, symptoms & prevention?

As several pharmaceutical companies rush to test their vaccines and other products in relation to the new variant, British drugmaker GSK has claimed that its antibody-based COVID-19 therapy is effective against the new Omicron variant of coronavirus.

GSK-Vir's Covid drug effective against Omicron variant: Study

French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.

Sanofi, GSK launch final phase of Covid vaccine trials

The US Food and Drug Administration (FDA) has authorised a monoclonal antibody drug against COVID-19, developed by GlaxoSmithKline and Vir, which claims to reduce hospitalisation and death among Coronavirus patients by 85 per cent and is also effective against the variants.

US FDA authorises GSK-Vir monoclonal antibody drug for Covid

Britain`s GSK will shift production of the world`s first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.

GSK to move malaria vaccine production to India's Bharat Biotech

France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.

Sanofi, GSK Covid vaccine delayed until end of 2021

The US government will pump in $2.1 billion in two pharma companies Sanofi and GlaxoSmithKline(GSK) to combat the coronavirus pandemic as part of Operation Warp Speed.

Trump administration to pump $2.1 billion for Sanofi, GSK coronavirus vaccine

China has started human trials of its sixth experimental COVID-19 vaccine. The vaccine is being tested with the help of the UK's GlaxoSmithKline (GSK) and the US' Dynavax.

COVID 19: Human trials for potential vaccine begins; initial results expected in August

GlaxoSmithKline on Wednesday raised its annual profit forecast for the second time this year as sales of its shingles vaccine beat expectations and older medicines, including HIV treatments, continued to sell well.

GSK raises profit forecast after shingles vaccine sales boost

Gsk, News on Gsk, stories on Gsk, articles on Gsk, Gsk stories at Wion, Gsk news, Gsk latest news

gsk